The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients

Warmenhoven, Franca; Rijswijk, Eric van; Engels, Yvonne; Kan, Cornelis C.; Prins, Judith B.; Weel, Chris van; Vissers, Kris

doi:10.1007/s00520-010-1082-8

Cited by 81 publications

(75 citation statements)

References 36 publications

(33 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It is developed to rate the severity of depressive symptoms (17) and exists of 13 clusters of 4 statements, ranking from 0 to 3, increasing in depression symptoms; in addition, a total score of 0-3 indicates minimal depression, 4-11 mild depression, 12-16 moderate depression and ≥17 severe depression. This questionnaire is accurate for somatic patients (18) and has been validated in many samples including cancer patients (19). Since no different cut off points indicating depression after breast cancer diagnosis are described in literature, the cut off values of the BDI-13 as stated above were used.…”

Section: Methodsmentioning

confidence: 99%

Breast reconstruction after mastectomy: does it decrease depression at the long-term?

Raaff¹,

Derks

Torensma³

et al. 2016

Gland Surg.

View full text Add to dashboard Cite

Background: Depression is associated with breast cancer survivors in 22%. Although breast reconstruction (BR) is intended to provide psychological improvements such as reducing depression, literature is inconclusive and without long-term follow-up. The objective is to evaluate the impact of BR after breast cancer related mastectomy on the long-term depression risk and assess predictive factors for depression.Methods: Women who underwent a curative mastectomy between 1999 and 2009 were included. After a mean follow-up of more than 6 years after operation, the Beck Depression Inventory-13 (BDI-13) evaluated depressive symptoms. Multivariable regression analysis provided predictors for depression.Results: A total of 139 patients, 34 (24.5%) with and 105 (75.5%) without BR, were analyzed. Seventyseven patients (48.2%) were at high risk for mild (n=58), moderate (n=5) or severe (n=4) depression. There was a trend for slightly better BDI-13 outcomes for women who underwent BR (2 vs. 4; P=0.06). Living alone [odds ratio (OR): 2.16; P=0.04], low educational level (OR: 3.70; P<0.01) and adjuvant hormonal/ endocrine-therapy (OR: 2.36; P=0.02) were associated with an increased depression risk.Conclusions: BR has no clear influence on depressive symptoms on the long-term. Predictive factors should alert clinicians to assess depressive symptoms in specific breast cancer patients during follow-up. significantly increased risk of death from all causes within 5 years (hazard ratio: 3.59; 95% CI: 1.39-9.24). Another study found a hazard ratio for all-cause mortality in breast cancer patients of 1.27 (95% CI: 0.58-2.79) (7).After mastectomy, most women are given the option of either immediate (IBR) or delayed (DBR) breast reconstruction. Although these procedures are intended to provide cosmetic and psychological improvements, such as possible reduction of depression when compared to mastectomy without breast reconstruction (BR), contrasting reports have been written about these improvements. Multiple studies noted a significant decrease in depression in the reconstruction group (8-12), whereas in a number of other studies no psychological improvements were found in both IBR and DBR groups during follow-up periods of 6 months to 2 years after surgery (13,14). In view of the clinical possible consequences of BR, such as prolonged recovery time, risks of complications or the need of additional surgery, data should be available regarding the advantages of these surgical procedures including the influence on depression risk.Since the combined data of previous studies are not only inconclusive, but also lack long-term follow-up, more research is needed on the effect of post-mastectomy BR on the long-term risk and severity of depression. In order to optimize pre-operative education and patient selection for BR, we evaluated the impact of BR on depression at the long-term, using the 13-item BDI (BDI-13). Methods Study design and study populationA single-institute cohort study was performed by using hospital databases. Only women who und...

show abstract

Section: Methodsmentioning

confidence: 99%

Breast reconstruction after mastectomy: does it decrease depression at the long-term?

Raaff¹,

Derks

Torensma³

et al. 2016

Gland Surg.

View full text Add to dashboard Cite

show abstract

“…With regard to psychometric options, the BDI-II [9] is one of the most commonly used [10,11]. The BDI-II measures a patient's severity level of depression: none/minimal, mild, moderate, or severe.…”

Section: Introductionmentioning

confidence: 99%

“…Using an impressive receiver operating characteristic (ROC) curve analysis, the authors observed a sensitivity of 79.4% and a specificity of 80.8% for distinguishing not depressed versus depressed patient selfratings. Reference [11] compared the mood section of the PRIME-MD [19] to a single depression question and the BDI-II (with cutoff scores of 14 and 16). The single question "Are you feeling depressed?"…”

Section: Introductionmentioning

confidence: 99%

Convergent Validity of a Single Question with Multiple Classification Options for Depression Screening in Medical Settings

Fouty¹,

Sanchez²,

Weitzner³

et al. 2014

GSTF J Psych

View full text Add to dashboard Cite

Keywords-convergent validity; depression screening; single question; BDI-II; severity level I. INTRODUCTIONDepression is one of the most common mental illnesses globally in both medical and non-medical populations. The World Health Organization noted that in 17 countries 1 in 20 people reported having an episode of depression in the past year [1]. In the United States, the Centers for Disease Control and Prevention reported a 9.1% prevalence rate of current depression in the general population [2]. Reference [3] observed a lifetime prevalence of 16.6% for major depression with a lifetime morbid risk of 29.9% for persons 13 years of age and older. The prevalence of depression in medically ill persons has been reported to be significantly higher than healthy persons, with rates ranging from 20% to 40% [4]. As staggering as these rates may seem, in an examination of the existing literature, categorical prevalence rates of depression in patients with comorbid medical illnesses as high as 75% have been reported [5]. The importance of considering prevalence rates in medically ill persons lies in the finding that 47.6% of psychologists in the United States work in medical settings [6,7]. It is therefore essential that frontline healthcare professionals working in medical settings be able to quickly and effectively evaluate and screen for depressive symptomology.Depression is assessed through self-report questionnaires or a structured clinical interview (e.g., SCID-CV) [8]. With regard to psychometric options, the BDI-II [9] is one of the most commonly used [10,11]. The BDI-II measures a patient's severity level of depression: none/minimal, mild, moderate, or severe. An evaluation of the psychometric properties of the BDI-II has demonstrated that this instrument yields reliable, internally consistent, and valid assessments of depression in medical care settings [12].Due to the time-limited nature of assessment often observed in medical settings, efforts should be made to develop screening procedures that are valid, yet brief enough to be administered to medically ill persons. Previous studies have investigated the effectiveness of a one or two question format as a means of screening for depression in medical settings. A single depression question format entails comparing patient responses to a depression question (e.g., "Are you depressed?") to a clinical interview. In a two question format, the depression question is combined with a loss of interest question (e.g., "Have you experienced loss of interest in things or activities that you would normally enjoy?"). Patient responses are again typically compared to a diagnosis from a structured clinical interview.Results are presented in terms of sensitivity and specificity. Sensitivity refers to the true positive rate; the degree of agreement between patients who describe themselves as depressed and a finding of depression on the secondary measure (typically a clinical interview). Specificity is the true negative rate; the degree of agreement between those who identify them...

show abstract

“…Tanısı zamanında konulup gerekli destek tedavi sağlanmadığında, farmokolojik ve fizyolojik tedavilerin de yararı azalabilir. [5,6] Depresyon tanısında çeşitli anket formları, klinik diyaloglar veya özet tarama programları kullanılmış olup, en sık kullanılan tarama testi Beck Depresyon Ölçeği-dir (BDÖ). [7] BDÖ ile tanının konulması yanında depresyon şiddeti de ölçülebilir, buna göre hastanın psikiyatrik desteğe ihtiyacı olup olmadığı belirlenir.…”

Section: Introductionunclassified

Depression Analysis in Patients Treated with Chemotherapy: Single Center Experience

Ustaalıoğlu¹,

Öztürk²,

Er³

et al. 2014

J Kartal TR

View full text Add to dashboard Cite

ÖzetAmaç: Kanserli hastalarda depresyon en sık görülen psikiyatrik sorundur. Depresyonun erken tanı ve tedavisi, hastaların tedaviye uyumunu ve yaşam kalitesini artıracaktır. Biz kemoterapi alan hastalarımızda depresyon varlığı ve psikiyatrik destek gereksinimini değerlendirdik.Gereç ve Yöntem: Çalışmamızda, kemoterapi ünitemizde tedavi almak için gelen 155 hastayı değerlendirdik. Hastaların depresyon varlığını ve düzeyini belirlemek için Beck Depresyon Ölçeği (BDÖ) kullandık. Hastaların kişisel ve klinik özel-likleriyle psikiyatrik destek gereksinimi arasındaki ilişkilerini ki-kare testi ile değerlendirdik. Bulgular:Hastalarımızın yaş ortalaması 58 (21-78) idi. Hastalarımızın 61.9%'u erkek olup, çoğunluğu emekli idi. BDÖ'ye göre ortanca depresyon puanı 9 (0-41) olarak bulundu. Depresyon sınıflaması; %10.3 (n=16) ciddi, %10.3 (n=16) orta, %27.1 (n=42) hafif depresyondu. Geriye kalan 81 hastada (%52.3) depresyon saptanmadı. Metastaz varlığı ve aldığı kemoterapi şekli ve progresyon varlığı psikiyatrik tedavi gereksinimi ile ilişkili olarak bulundu (p<0.05).Sonuç: Kanserli hastalarda depresyonun tanısı ve derecelendirmesi ile hastaya uygun psikiyatrik desteğin sağlan-ması kanser tedavisinin bir parçasıdır. Bu süreçte hastalara psikososyal destek sağlamak kemoterapi ünitesi ve onkoloji çalışanları için bir görev olmalıdır.

show abstract

The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients

Cited by 81 publications

References 36 publications

Breast reconstruction after mastectomy: does it decrease depression at the long-term?

Breast reconstruction after mastectomy: does it decrease depression at the long-term?

Convergent Validity of a Single Question with Multiple Classification Options for Depression Screening in Medical Settings

Depression Analysis in Patients Treated with Chemotherapy: Single Center Experience

Contact Info

Product

Resources

About